Director, Global Value, Access & Pricing; Solid Tumors, Pipeline

Pipeline Market Access Strategy Development

Lead the creation and implementation of global pricing and market access strategies for ST pipeline products (typically but not exclusively Phase II and III assets), aligning with clinical and commercial goals.
Collaborate cross-functionally to integrate access requirements into the development process, influencing trial design, endpoints, and evidence generation to meet payer needs.

Value Proposition & Evidence Generation

Develop early value propositions that resonate with global payers and support future pricing, reimbursement, and access decisions.
Work closely with Clinical, Medical Affairs, and Health Economics & Outcomes Research (HEOR) teams to shape clinical trial design and evidence-generation strategies that align with target market access requirements.
Identify and prioritize evidence gaps; work closely with HEOR to ensure development of health economic models, burden-of-illness studies, and other data to address payer concerns and enhance product differentiation.

Cross-Functional Collaboration & Stakeholder Engagement

Represent the GVAP ST perspective (aligned with Regions and/or focus markets and HEOR) to governance or oversight bodies of the Company (e.g., GPT, GBT)
Serve as the primary market access point of contact for one or more GPTs
Collaborate with R&D, Commercial (incl. PSV), Medical Affairs, and Regulatory Affairs to ensure access-related insights and payer needs are integrated into the overall development strategy
Provide input into clinical decisions and Business Development to ensure payer requirements are recognized, addressed and or additional evidence generated through other means, in support of the commercial strategy development expectations, trends and risks
Engage with focus markets and regional access teams to ensure early alignment on access strategies and support local adaptation for specific market needs

Pre-Launch Preparation

Drive pre-launch planning for pipeline products, including the creation of early value toolkits and JCA relevant PICOs and early engagement strategies to optimize future access and reimbursement.
Support market access launch readiness through regular communication, training, and support to regional and affiliate teams, preparing them to engage with payers as the product nears market entry.
Support regional activities relating to regional asset in-licensing for early pipeline products.

Market Insights & Competitive Landscape Analysis

Continuously monitor the solid tumor landscape, including competitor activities, evolving payer requirements, and regulatory changes that impact access and reimbursement.
Run analysis of payer insights, pricing trends, and market conditions to inform strategy adjustments and refine access plans.
Use global and regional insights to refine value propositions and enhance product positioning as the product advances through clinical phases.
Lead early pipeline consultation processes with payers across all regions (in collaboration with the regions and/or focus markets) (e.g., CADTH, NICE, etc.)

Supervisory Responsibilities

No direct supervision, high level of cross functional and pan-regional collaborations with internal stakeholders.